{"resourceType": "EvidenceVariable", "identifier": [{"type": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}], "text": "FEvIR Object Identifier"}, "system": "https://fevir.net/FOI", "value": "236551", "assigner": {"display": "Computable Publishing LLC"}}, {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-313880", "assigner": {"display": "Computable Publishing LLC"}}, {"type": {"text": "outcomeId"}, "system": "https://app.magicapp.org/#/guidelines", "value": "313880"}, {"type": {"text": "picoId"}, "system": "https://app.magicapp.org/#/guidelines", "value": "85789"}, {"type": {"text": "sectionId"}, "system": "https://app.magicapp.org/#/guidelines", "value": "73212"}], "name": "End_stage_kidney_disease313880", "title": "OutcomeDefinition: End-stage kidney disease", "shortTitle": "End-stage kidney disease", "status": "active", "description": "End-stage kidney disease", "author": [{"name": "Computable Publishing\u00ae: MAGIC-to-FEvIR Converter"}], "relatesTo": [{"type": "part-of", "targetReference": {"type": "Composition", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-conversion-report", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes"}}], "definition": {"concept": {"text": "End-stage kidney disease"}}, "meta": {"versionId": "67", "lastUpdated": "2025-10-07T17:12:54.639Z"}, "url": "https://fevir.net/resources/EvidenceVariable/236551", "id": "236551", "publisher": "Computable Publishing LLC", "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/", "contact": [{"telecom": [{"system": "email", "value": "support@computablepublishing.com"}]}], "citeAs": "OutcomeDefinition: End-stage kidney disease [Database Entry: FHIR EvidenceVariable Resource]. Contributors: Computable Publishing\u00ae: MAGIC-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 236551. Revised 2025-10-07. Available at: https://fevir.net/resources/EvidenceVariable/236551. Computable resource at: https://fevir.net/resources/EvidenceVariable/236551#json.", "handling": "dichotomous"}